Pandemic influenza split vaccine (Hualan bio)
大流行流感裂解疫苗（华兰生物）
Report date: 2023/06/28 17:07:31
Base Information
Drug NamePandemic influenza split vaccine (Hualan bio)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Microbiology And Epidemiology, Chinese Academy Of Military Medical SciencesHualan Ankang Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesHualan Biological Engineering IncInstitute Of Microbiology And Epidemiology, Chinese Academy Of Military Medical Sciences
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A